2021
DOI: 10.21873/anticanres.15059
|View full text |Cite
|
Sign up to set email alerts
|

Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant

Abstract: Background/Aim: This study explored the mechanisms of the allogeneic graft versus leukemia effect in acute lymphoblastic leukemia (ALL) cells by examining whether they change gene expression in the post-transplant environment containing cytokines and the immunosuppressant cyclosporine, and if such changes affect ALL cell survival. Materials and Methods: RNASeq was used to assess leukemia global gene expression and flow cytometry to measure ALL survival in the presence of T cells, NK cells, cytokines, and cyclo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Currently, gene expression in the context of the HSCT procedure is described primarily in the aspect of tracking the differentiation of transplanted hematopoietic stem cells [ 19 , 20 ] or in assessing the expression of genes related to the possibility of disease relapse and disease-free survival [ 21 , 22 , 23 , 24 ]. Moreover, it is known that the HSCT procedure with subsequent immunosuppressive treatment affects the expression of leukemic cells [ 25 ]. Our first attempt to assess this dependency in 2016 [ 26 ] resulted in a better understanding of the genetic background of immune complications after the HSCT procedure, but due to the improvement of available research tools and the updating of genetic databases, we decided to reassess the collected material.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, gene expression in the context of the HSCT procedure is described primarily in the aspect of tracking the differentiation of transplanted hematopoietic stem cells [ 19 , 20 ] or in assessing the expression of genes related to the possibility of disease relapse and disease-free survival [ 21 , 22 , 23 , 24 ]. Moreover, it is known that the HSCT procedure with subsequent immunosuppressive treatment affects the expression of leukemic cells [ 25 ]. Our first attempt to assess this dependency in 2016 [ 26 ] resulted in a better understanding of the genetic background of immune complications after the HSCT procedure, but due to the improvement of available research tools and the updating of genetic databases, we decided to reassess the collected material.…”
Section: Introductionmentioning
confidence: 99%